Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Treatment with Sandostatin and in vivo localization of tumors with radiolabeled somatostatin analogs

Journal Article · · Metabolism, Clinical and Experimental; (USA)
The presence of high numbers of somatostatin receptors seems to be the basis for the successful control by Sandostatin of hormonal hypersecretion by most growth hormone-secreting pituitary adenomas, endocrine pancreatic tumors, and carcinoids. In this report, we present preliminary data on in vivo somatostatin receptor imaging with a {sup 123}I-coupled somatostatin analog (204-090) in patients with these types of tumors.
OSTI ID:
6421621
Journal Information:
Metabolism, Clinical and Experimental; (USA), Journal Name: Metabolism, Clinical and Experimental; (USA) Vol. 39:9 Suppl 2; ISSN METAA; ISSN 0026-0495
Country of Publication:
United States
Language:
English